glp-1 Weight-loss medicine Fitness
Semaglutide is a long-acting dosage form developed based on the basic structure of liraglutide, and its effect in the treatment of type 2 diabetes is better.
Semeglutide is a new GLP-1 analog that is injected subcutaneously once a week. Semaglutide is a long-acting GLP-1 analog. Compared with liraglutide, semaglutide has a longer aliphatic chain and increased hydrophobicity, but semaglutide is modified with a short-chain PEG, which greatly enhances its hydrophilicity. After modification, PEG can not only bind tightly to albumin, mask the hydrolysis site of DPP-4 enzyme, but also reduce renal excretion, extend biological half-life, and achieve long circulation.
Product Name | Semaglutide |
---|---|
CAS NO. | 910463-68-2 |
Purity | 99% |
Molecular Formula | C187H291N45O59 |
MOQ? | 10 vials |
1.What's your payment terms?
Standard terms: T/T in advance and . Also L/C at sight is acceptable for large amount.
2.What's your shipping time?
We have bulk in stock, which means we can ship it to you immediately.
3.How do you ensure the quality of your products?
Strict QC with 6 steps testing from raw material purchase to finished product.
4.How do you ship the order normally?
For large qty order,ship the goods by sea. For small qty order, by air or express. We supply optional express for you, including DHL, FEDEX,UPS,TXT,EMS,and so on.
5.What's your loading port?
Usually Beijing, Shanghai, Qingdao, Tianjin, Guangzhou
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View